Kendall Capital Partners

Venture Capital

Cambridge-based VC investing in early-to-commercial stage life sciences and healthcare companies; portfolio includes Rejuvenate Bio and EpiBone.

Cambridge, United States · 3+ investments · 3 portfolio companies

Early Stage
Growth
Biotech
Diagnostics
Gene Therapy
Healthcare
Life Sciences
Headquarters
Cambridge, United States
Founded
2021
Portfolio Companies
3
Total Investments
3
Last Investment
Nov 2024

Investment Thesis

Early-to-commercial stage life sciences and healthcare innovations addressing urgent global medical needs including gene therapy, cell therapy, and AI-enabled diagnostics.

Kendall Capital Partners is a Venture Capital firm based in Cambridge, United States. It has made 3 investments, including EYENUK, INC., EPIBONE, INC. and REJUVENATE BIO INC. Focus areas include Biotech and Diagnostics.

Portfolio3

Co-investors6

Sign up to view co-investors

6 co-investors across 6 shared portfolio companies — who they back alongside, and how often they lead.

Venture Capital ×5 · Private Equity ×1 · 6 shared rounds

Investment History

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

Kendall Capital Partners on Indexed.vc
<a href="https://indexed.vc/investors/kendall-capital-partners"><img src="https://indexed.vc/api/badge/investor/kendall-capital-partners" alt="Kendall Capital Partners on Indexed.vc" width="260" height="76" /></a>